ORAMED PHARMACEUTICALS INC. (ORMP)

SEC filing

ORAMED PHARMACEUTICALS INC.

ORMP · CIK 1176309

4 · Oct 2, 2026 · Chief Financial Officer Gabay Avraham sold 20K shares at $4.51/share ($90,200)

Chief Financial Officer Gabay Avraham sold 20K shares at $4.51/share ($90,200)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.